STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	May 31, 2013	May 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (6,015,204)	$ (4,942,273)
Depreciation and amortization	1,275,190	1,494,681
Bad debt expense		23,145
Common stock issued for services	46,251
Deferred income tax benefits		(2,618,723)
Loss on sale or disposal of fixed assets	895
Share-based compensation expense	1,051,901	1,410,627
Changes in operating assets and liabilities:
Accounts receivable	(546,400)	15,313
Prepaid expenses and other current assets	(120,675)	65,579
Interest on restricted cash	(88)
Deposits	12,795	(113,633)
Accounts payable and accrued liabilities	(979,342)	697,608
Deferred revenue	259,934	(190,356)
Long-term liabilities	(16,467)	(20,313)
NET CASH USED IN OPERATING ACTIVITIES	(3,722,650)	(4,112,863)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for purchase of patents	(45,520)	(566,983)
Cash paid for patent defense costs	(182,669)	(1,393,222)
Cash paid for acquisition related contingent consideration		(2,000,000)
Cash paid for long-term investment		(200,000)
NET CASH USED IN INVESTING ACTIVITIES	(228,189)	(4,160,205)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds received from line of credit	1,000,000
Proceeds received from the exercise of stock options and warrants, net	2,500	86,883
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,002,500	86,883
NET CHANGE IN CASH AND CASH EQUIVALENTS	(2,948,339)	(8,186,185)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	4,352,691	11,428,825
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,404,352	3,242,640
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	889
Income taxes paid
Non-cash investing activity:
Stock issued for asset purchase		$ 3,813,953